Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;21(2):312-8.
doi: 10.1111/ene.12309. Epub 2013 Dec 7.

Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience

M Zibetti  1 , A Merola, C A Artusi, L Rizzi, S Angrisano, D Reggio, C De Angelis, M Rizzone, L Lopiano
Affiliations
Free article

Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience

M Zibetti et al. Eur J Neurol. 2014 Feb.
Free article

Abstract

Background and purpose: Levodopa/carbidopa intestinal gel (LCIG) infusion is nowadays becoming an established therapeutic option for advanced Parkinson's disease (PD) patients with fluctuating symptoms unresponsive to conventional oral treatment. As the implementation of LCIG therapy is increasing, there is a need for safety and efficacy data from current clinical practice.

Methods: All PD patients treated with LCIG at our centre over a 7-year period were analysed to determine the duration of treatment, retention rate, reasons for discontinuation, LCIG efficacy in motor complications, modifications of concomitant therapy and adverse events.

Results: Of the 59 patients, seven subjects (12%) died of causes unrelated to LCIG infusion and 11 patients (19%) discontinued therapy prior to the cut-off date. Duodopa improved motor complications and over 90% of patients reported an improvement in their quality of life, autonomy and clinical global status. The most common adverse events were dislocation and kinking of the intestinal tube.

Conclusions: LCIG infusion is effective for the long-term treatment of advanced PD patients and exerts a positive and clinically significant effect on motor complications with a relatively low dropout rate.

Keywords: Parkinson's disease; duodopa; levodopa/carbidopa intestinal gel infusion; long-term follow-up.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles